Shravanthi R. Gandra, Ph.D.
Affiliations: | 2005 | University Of Louisiana at Monroe |
Area:
Pharmacy, Health Care ManagementGoogle:
"Shravanthi Gandra"Parents
Sign in to add mentorLesa Lawrence | grad student | 2005 | University Of Louisiana at Monroe | |
(Development of a risk stratification tool for predicting hospitalization from macrovascular complications among diabetic patients in a managed care environment.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Blieden M, Gandra SR, Cheng LI, et al. (2017) Differences in utility elicitation methods in cardiovascular disease: a systematic review. Journal of Medical Economics. 1-23 |
Rosenson RS, Gandra SR, McKendrick J, et al. (2017) Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries. Cardiovascular Drugs and Therapy |
Villa G, Lothgren M, Kutikova L, et al. (2017) Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain. Clinical Therapeutics |
Punekar RS, Fox KM, Paoli CJ, et al. (2017) Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study. Current Medical Research and Opinion. 1-8 |
Deshpande S, Quek RG, Forbes CA, et al. (2017) A systematic review to assess the adherence and persistence with statins. Current Medical Research and Opinion. 1-23 |
Burke JP, Simpson RJ, Paoli CJ, et al. (2016) Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy. Journal of Clinical Lipidology. 10: 1470-1480.e3 |
Gordois AL, Toth PP, Quek RG, et al. (2016) Productivity losses associated with cardiovascular disease: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research |
Wei CY, Quek RG, Villa G, et al. (2016) A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. Pharmacoeconomics |
Nicholson G, Gandra SR, Halbert RJ, et al. (2016) Patient-level costs of major cardiovascular conditions: a review of the international literature. Clinicoeconomics and Outcomes Research : Ceor. 8: 495-506 |
Forbes CA, Quek RG, Deshpande S, et al. (2016) The relationship between Lp(a) and CVD outcomes: a systematic review. Lipids in Health and Disease. 15: 95 |